1 Zhong Yuan Academy of Biological Medicine, Liaocheng People’s Hospital, Liaocheng, China 2 Deparment of Gastrointestinal Surgery, Liaocheng People’s Hospital, Liaocheng, China Background: The high ...
Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with artificial-intelligence-powered analysis to provide what the company says could become ...
The FDA expanded the approval of trastuzumab deruxtecan (T-DXd, Enhertu) to include treatment of unresectable/metastatic hormone receptor (HR)-positive, HER2-low ...
The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast cancer, based on phase 3 DESTINY-Breast06 trial results. The FDA has granted ...
Background: Our previous research highlighted the potential role of immunoglobulin G4 (IgG4) in mediating immunosuppression within the tumor microenvironment (TME). Tertiary lymphoid structures (TLS) ...
Abstract: Immunohistochemistry (IHC) examination is essential to determine the tumour subtypes, provide key prognostic factors, and develop personalized treatment plans for breast cancer. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback